Teikoku Pharma USA, Inc. - Product Pipeline Review - 2012 - new company profile report

London 7/20/2012 02:36 AM GMT (TransWorldNews)

Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012 - This pharmaceuticals report, "Teikoku Pharma USA, Inc. - Product Pipeline Review - 2012" provides data on the Teikoku Pharma USA, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from our proprietary databases, Teikoku Pharma USA, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Teikoku Pharma USA, Inc. and industry-specific third party sources, put together by our team.

Scope

- Teikoku Pharma USA, Inc. - Brief Teikoku Pharma USA, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Teikoku Pharma USA, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Teikoku Pharma USA, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Teikoku Pharma USA, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Teikoku Pharma USA, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Teikoku Pharma USA, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Teikoku Pharma USA, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Teikoku Pharma USA, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Teikoku Pharma USA, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Teikoku Pharma USA, Inc.; Teikoku Pharma USA, Inc. - Key Therapeutics; Teikoku Pharma USA, Inc. - Pipeline Overview and Promising Molecules; Teikoku Pharma USA, Inc. - News; Teikoku Pharma USA, Inc. - Latest Updates; Teikoku Pharma USA, Inc. - Pipeline; Teikoku Pharma USA, Inc. - Discontinued/Dormant Projects



Click for Report details:Teikoku Pharma USA, Inc. - Product Pipeline Review - 2012



enquiries@companiesandmarkets.com
www.companiesandmarkets.com/Market/Healthcare-and-Medical/Company-Profile/Teikoku-Pharma-USA-Inc-Product-Pipeline-Review-2012/RPT1092804?aCode=e7702a5b-ad88-47dd-bb7a-a58072d4bda2

 

News Alerts

Receive alerts for Companiesandmarkets.com to your inbox. Sign up for News Alerts